In the following video, Fool.com contributor Maxxwell Chatsko updates investors on Solazyme's huge cash position. When the developmental stage company released first-quarter earnings earlier this month, investors learned that cash and cash equivalents stood at $239 million. That may not be a large sum of money for other companies, but it can go a long way for Solazyme as it builds out commercial scale.
The company is still pretty far away from reaching its targeted capacity additions over the next several years. Solazyme will have a global operational capacity of just over 125,000 metric tons by mid-2015, with an additional 325,000 metric tons of capacity on the way in the next several years. Investors are right to enjoy the cash hoard at the company, but should remember that substantially more money will be needed in the next few years.
The article How Long Can Solazyme's Cash Hoard Last? originally appeared on Fool.com.Erin Miller has no position in any stocks mentioned. Motley Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio , his CAPS page , or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies. The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.